Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICARuS: EPIC vs HIPEC After Cytoreductive Surgery for Appendiceal and Colorectal Cancer
NCT01815359Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Mar 2013
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mitomycin c, floxuridine, folinic acid in appendiceal cancer, colorectal cancer (CRC), sponsored by Memorial Sloan Kettering Cancer Center. Started Mar 2013; status: active, not recruiting.
02
Drugs
mitomycin cfloxuridinefolinic acid
03
Conditions
appendiceal cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01815359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01815359.